Benzinga | May 11, 2021 07:39AM EDT

JP Morgan Initiates Coverage On Akoya Biosciences with Overweight Rating, Announces Price Target of $23

JP Morgan analyst Tycho Peterson initiates coverage on Akoya Biosciences (NASDAQ:AKYA) with a Overweight rating and announces Price Target of $23.